HYCAMTIN 1mg and 4mg solution
- Name:
HYCAMTIN 1mg and 4mg solution
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/11/20

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 9 November 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 9 November 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 13 August 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
Updated on 17 December 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 28 March 2019 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 5 November 2018 PIL
Reasons for updating
- Change to section 6 - marketing authorisation number
Updated on 21 May 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 January 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 29 January 2018 PIL
Reasons for updating
- Change to section 4 - possible side effects
- Improved presentation of PIL
Updated on 10 January 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 11 October 2017 PIL
Reasons for updating
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 25 May 2016 PIL
Reasons for updating
- Change to marketing authorisation holder
Updated on 16 November 2015 PIL
Reasons for updating
- Previous version of PIL reinstated
Updated on 6 October 2014 PIL
Reasons for updating
- Addition of information on reporting a side effect.
- Change to date of revision
- Transfer of Marketing Authorisation Holder
Updated on 6 January 2014 PIL
Reasons for updating
- Change to side-effects
Updated on 30 August 2013 PIL
Reasons for updating
- Change of distributor details
Updated on 7 February 2011 PIL
Reasons for updating
- Change to side-effects
Updated on 7 April 2009 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
- Change to appearance of the medicine
- Change to side-effects
- Change to packaging
Updated on 21 August 2008 PIL
Reasons for updating
- Change to information about pregnancy or lactation
Updated on 12 June 2008 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 4 April 2007 PIL
Reasons for updating
- Change to side-effects
Updated on 4 August 2005 PIL
Reasons for updating
- Improved electronic presentation
Updated on 28 October 2004 PIL
Reasons for updating
- New PIL for medicines.ie